Related Experiment Videos
Plasma 1.25-dihydroxyvitamin D concentrations in preterm infants
Acta Paediatrica Scandinavica
|July 1, 1985
Summary
Preterm infants can produce high levels of 1.25-dihydroxyvitamin D, a crucial vitamin D metabolite. This study tracked these levels in preterm infants, finding they exceeded adult concentrations without signs of rickets.
Area of Science:
- Pediatrics
- Endocrinology
- Nutritional Science
Background:
- Preterm infants face unique nutritional challenges.
- Vitamin D metabolism is critical for bone health in infants.
- Understanding vitamin D metabolite levels in preterm infants is essential.
Purpose of the Study:
- To measure 1.25-dihydroxyvitamin D concentrations in preterm infants.
- To compare these levels with those in adults.
- To assess potential correlations with clinical and biochemical parameters.
Main Methods:
- Measured 1.25-dihydroxyvitamin D in 10 preterm infants over 12 weeks.
- Monitored nutritional intake (parenteral and enteral feeding, vitamin D3 supplementation).
- Assessed clinical, chemical, and radiological signs of rickets.
Main Results:
- 1.25-dihydroxyvitamin D levels were highly variable but generally high in preterm infants.
- Mean levels at 6, 9, and 12 weeks were significantly higher than in adults.
- No correlation found between 1.25-dihydroxyvitamin D and 25-hydroxyvitamin D, calcium, phosphorus, or alkaline phosphatase.
Conclusions:
- Preterm infants demonstrate a capacity for producing elevated plasma 1.25-dihydroxyvitamin D.
- High levels were observed despite standard vitamin D supplementation and without rickets.
- Further research may explore the implications of these findings for preterm infant health.